久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實業有限公司Logo

熱門詞: 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥

當前位置: 首頁 > 所有品牌 > ISCO
ISCO
ISCO ISCO

美國國際干細胞公司 International Stem Cell Corporation


The Company was founded for the specific purposes of solving key problems in the emerging field of regenerative medicine, cell availability and immune rejection. There are growing numbers of cell transplant therapies that have already been demonstrated to be effective in treating major diseases such as diabetes, liver disease and retinal disease, and many others. What is not available is a reliable, renewable and essentially unlimited source of human cells for use in these transplant procedures. Existing embryonic stem cell lines produce cells that will be difficult to match to the patient’s immune system. Parthenogenetic stem cells can solve both of these problems.

ISCO’s goal is to be the universal supplier of therapeutic cells for:

All developing embryonic stem cell based therapeutic procedures.
 

The medical/scientific research community.

To achieve these goals, ISCO has set three objectives:

To create an abundant source of parthenogenetic stem cells to meet the rapidly growing research and therapeutic demands of regenerative medicine and provide those cells to researchers entering clinical trials.
 

To create stem cell lines from unfertilized eggs, which would have all the benefits of human embryonic stem cells, but are superior in their ability to eliminate or diminish immune rejection in patients.
 

To build a true “Cell Bank” using its existing technology that will allow for on-demand delivery of cells that could be matched to the patient’s own immune system and reduce or eliminate the need for immunosuppressant drugs.

ISCO scientists are confident that we have now made the scientific breakthroughs that will meet these objectives. ISCO has created the world’s first human cell lines through the use of parthenogenesis and has already created the parthenogenetic stem cell line that matches the most common immune type in the US population. These parthenote cell lines will, we believe, be critical to open the pathway to successful stem cell therapy.
 

關于我們客戶服務產品分類法律聲明
主站蜘蛛池模板: 欧美日韩亚洲第一页 | 国产一区二区在线免费观看 | 精品成人一区二区三区免费视频 | 欧美极品欧美精品欧美视频 | 国产在线啪 | 卡通动漫亚洲综合 | 欧美精品色精品一区二区三区 | 成人欧美一区二区三区在线 | 99精品国产免费久久国语 | 亚洲一二三区在线观看 | 明星国产欧美日韩在线观看 | 国产成人无精品久久久久国语 | 日韩经典第一页 | 在线免费黄色 | 欧美高清一区二区三区 | 香蕉视频网页版 | 日韩成人小视频 | 欧美日韩中文字幕在线 | 中文字幕免费 | 日韩高清一区二区三区不卡 | 国产一级毛片在线 | 日韩精品一区二区三区毛片 | 国产一区二区精品久久91 | 日韩精品在线免费观看 | 五十路完熟交尾 | 日韩欧美高清一区 | 国产日韩三级 | 中文字幕亚洲天堂 | 欧美成人猛男性色生活 | 成人欧美一区二区三区在线 | 中国一级全黄的免费观看 | www.香蕉视频在线观看 | 日韩午夜免费电影 | 日韩有码第一页 | 在线日韩亚洲 | 久久精品美女 | 国产成人一区在线播放 | 久热中文字幕在线精品首页 | 日韩欧美一二三区 | 欧美在线 | 亚洲 | 久久大香香蕉国产免费网vrr |